Submitted by amarin on Fri, 12/08/2017 - 04:49 Home ID Reference 9261 News title Amarin Announces Publication of Case Study Results Describing Reductions in Multiple Lipid Parameters for Individual Hyperlipidemic Patients Switched to Vascepa(R)
